Rohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
Rohto-Mentholatum (Vietnam) Co., Ltd. is recalling Rohto Cooling Eye Drops Max Strength because there is a lack of assurance regarding the product's sterility.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The product is an ophthalmic drug (eye drops) and the hazard is a lack of sterility, which poses a high risk of infection or harm to the user.
Plain-English summary
Rohto-Mentholatum (Vietnam) Co., Ltd. is recalling Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polysorbate 90, 0.2%), Sterile 0.4 FL OZ (13 mL), distributed by The Mentholatum Company.
The recall is being conducted due to a lack of assurance of sterility in the product.
This recall affects specific lots of the product distributed nationwide within the United States. Consumers should check their product's lot number and expiration date to see if it matches the affected batches.
The recalled product
- Product
- ROHTO (NAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80)
- Brand
- ROHTO
- Manufacturer
- Rohto-Mentholatum (Vietnam) Co., Ltd.
- Category
- Drug — Ophthalmic
- Hazard
- lack-of-sterility
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: 3H2V
- 3H3V
- Exp. Date 2026/07
- 3J1V
- 3J3V
- 3J4V
- 3J5V
- Exp. Date 2026/09
- 3K1V
- 3K2V
- Exp. Date 2026/10
- 4A2V
- Exp. Date 2026/12
- 4B1V
- 4B2V
- 4B3V
- Exp. Date 2027/01
- 4F1V
- 4F2V
- 4F3V
UPCs (2)
- 0310742011012
- 310742011012
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ROHTO
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
Same category
- HighLidocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- HighXylocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateFDA Recalls Xylocaine Injections Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- HighNaropin Injection Recall Over Particulate Matter Contamination
FDA (Drugs) · 2026-07-29
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29